Ozempic and similar weight loss drugs, known as GLP-1s, make people less hungry, but it doesn't seem to stop them from going out to eat. Bloomberg Businessweek's Deena Shanker joins Stacey Vanek Smith and Max Chafkin on the Everybody's Business podcast to unpack this new phenomenon and why the weight loss drug craze is actually benefiting the restaurant industry. -------- More on Bloomberg Television and Markets Like this video? Subscribe and turn on notifications so you don't miss any videos